178 related articles for article (PubMed ID: 21351825)
1. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of nasal mucoadhesive microspheres of sumatriptan succinate.
Jain SA; Chauk DS; Mahajan HS; Tekade AR; Gattani SG
J Microencapsul; 2009 Dec; 26(8):711-21. PubMed ID: 19888880
[TBL] [Abstract][Full Text] [Related]
3. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan.
Pardeshi CV; Rajput PV; Belgamwar VS; Tekade AR
J Microencapsul; 2012; 29(2):103-14. PubMed ID: 22047546
[TBL] [Abstract][Full Text] [Related]
4. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
6. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
Patil SB; Sawant KK
J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
[TBL] [Abstract][Full Text] [Related]
8. Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer.
Harikarnpakdee S; Lipipun V; Sutanthavibul N; Ritthidej GC
AAPS PharmSciTech; 2006 Feb; 7(1):E12. PubMed ID: 16584142
[TBL] [Abstract][Full Text] [Related]
9. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
Sankar C; Rani M; Srivastava AK; Mishra B
Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
[TBL] [Abstract][Full Text] [Related]
10. Double-phase hydrogel for buccal delivery of tramadol.
Kamel R; Mahmoud A; El-Feky G
Drug Dev Ind Pharm; 2012 Apr; 38(4):468-83. PubMed ID: 21942308
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
[TBL] [Abstract][Full Text] [Related]
13. Microparticulate drug delivery system containing tramadol hydrochloride for pain treatment.
Ciurba A; Todoran N; Vari CE; Lazăr L; Al Hussein S; Hancu G
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1135-42. PubMed ID: 25581980
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
15. Formulation and characterization of tramadol-loaded IPN microgels of alginate and gelatin: Optimization using response surface methodology.
Kumar P; Singh I
Acta Pharm; 2010 Sep; 60(3):295-310. PubMed ID: 21134864
[TBL] [Abstract][Full Text] [Related]
16. Predictable pulsatile release of tramadol hydrochloride for chronotherapeutics of arthritis.
Dabhi C; Randale S; Belgamwar V; Gattani S; Tekade A
Drug Deliv; 2010 Jul; 17(5):273-81. PubMed ID: 20524906
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization.
Hasçiçek C; Gönül N; Erk N
Farmaco; 2003 Jan; 58(1):11-6. PubMed ID: 12595032
[TBL] [Abstract][Full Text] [Related]
18. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability enhancement of ondansetron after nasal administration of Caesalpinia pulcherrima-based microspheres.
Suryawanshi SR; Thakare NP; More DP; Thombre NA
Drug Deliv; 2015; 22(7):894-902. PubMed ID: 24279581
[TBL] [Abstract][Full Text] [Related]
20. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
